AI
VIVO

AdvisorShares Investments’s Meridian Bioscience Inc VIVO Stock Holding History

AdvisorShares Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,500
Closed -$299K – 285
2022
Q1 		$299K Buy
+11,500
New +$274K 0.05% 137

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

AdvisorShares Investments's VIVO Position: Q2 2022 in Review

AdvisorShares Investments sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 11,500 shares — an estimated $299K sold.

AdvisorShares Investments first reported a position in VIVO in Q1 2022 and held it in 1 quarter. The position peaked at $299K in Q1 2022. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

  • AdvisorShares Investments reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
  • AdvisorShares Investments sold 11,500 Meridian Bioscience Inc shares in Q2 2022, an estimated $299K.
  • AdvisorShares Investments first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 1 quarter.
  • AdvisorShares Investments's Meridian Bioscience Inc position peaked at $299K in Q1 2022.
  • 216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on AdvisorShares Investments's 13F filing for Q2 2022, filed 8 Aug 2022.